info@shukrapharmaceuticals.com
+91 79 48981130
In a landmark moment for Indian healthcare, Shukra Pharmaceuticals Ltd. and Borns Medical Robotics Inc. formally entered a strategic partnership through a Memorandum of Understanding (MOU) on February 5, 2026, in New Delhi.
This collaboration marks a significant stride in the "Make in India" initiative, aiming to indigenize advanced surgical technology. The event saw participation from leading doctors from across India who had experienced the VEER robotic system firsthand.
Mr. Dakshesh Shah, CMD of Shukra Pharmaceuticals Ltd., opened with a powerful vision: "Every human being deserves advanced technology." He framed the partnership as a crucial step in democratizing global medical advancements, making them accessible to all societal strata and actively fostering national self-reliance in cutting-edge healthcare innovation.
CMD, Shukra Pharmaceuticals Ltd.
CEO & Global Head, Shukra Pharmaceuticals
Dr. Minakshi Late, Group CEO & Global Head, detailed the mission's core pillars: uncompromising quality, affordability, and accessibility. She championed robotic surgery as a transformative point-of-care innovation for the future. This vision directly aligns with national healthcare priorities to establish advanced robotic surgery as a cornerstone of India's medical landscape.
Founder and CEO, Borns Medical Robotics Inc.
We envision a world where every surgeon, in any operating room, is empowered by intuitive robotic assistance. Our mission is to make this advanced standard of care universally accessible, turning today's cutting-edge innovation into tomorrow's routine practice. This standard isn't defined by technology for its own sake, but by the human outcomes it enables: smaller incisions, reduced trauma, shorter hospital stays, and a faster return to life. At borns medical robotics inc., we measure our success by your recovery.
CMO, Borns Medical Robotics Inc.
Dr. Alexander Tobias Teichmann, CMO of Borns Medical Robotics Inc., presented the VEER robotic surgery platform, highlighting its precision, efficiency, and transformative potential in modern healthcare. Speaking with conviction, he stated, "Robotics is the future of surgery," emphasizing how advanced robotic systems will redefine surgical outcomes and elevate patient care standards worldwide.
Senior Director & Head – Max Institute of Minimal Access, Bariatric & Robotic Surgery
Dr. Bindal, highlighted VEER's exceptional precision and its potential to redefine surgical excellence in India. He emphasized how the platform empowers surgeons with enhanced control, accuracy, and confidence, ultimately leading to improved patient outcomes and setting new benchmarks for advanced surgical care across the country.
The partnership between Shukra Pharmaceuticals and Borns Medical Robotics represents more than a business agreement—it's a commitment to advancing healthcare accessibility across India.
By bringing world-class robotic surgery technology to Indian hospitals at an affordable cost, this collaboration aims to democratize advanced surgical care and position India as a global leader in medical technology innovation.
Thrilled to announce a landmark moment as Shukra Pharmaceuticals Limited received the Letter of Intent for 10 acres in the visionary Medical Devices Park from Yamuna Expressway Industrial Development Authority (YEIDA).
This is more than an allocation of land; it’s a cornerstone in the blueprint to establish Uttar Pradesh as a global epicentre for medical technology and healthcare innovation, under the dynamic leadership of Hon’ble CM Shri Yogi Adityanath Ji and the proactive initiative of Invest UP.
At the heart of this dream is a simple, powerful vision by Managing Director Shukra pharmaceuticals Ltd, Mr. Dakshesh Shah: “To provide the best medical technology at an affordable cost, ensuring that every individual across India has access to proper treatment”. This vision is more than words it is a commitment to bridge innovation with accessibility, transforming advanced medical technology into everyday healthcare that reaches every corner of the nation.
Gratitude to Shri Rakesh Kumar Singh, CEO, YEIDA, and Shri Shailendra Bhatia, ACE CEO, for their invaluable support. From our side, the journey was steered by Dr. Minakshi Late (CEO & Global Head), along with Gaurav Shokeen (COO), Anil Kumar Verma (VP), and Kamini Bharti (Business Unit Head).
A proud step towards Aatmanirbhar Bharat and a healthier future for all.
